← Back to all trials
Enrolling By Invitation
NCT07450664
Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome
Sex: All
Ages: 4 Years – N/A
Healthy volunteers: No
Enrollment: 200
Sponsor: Soleno Therapeutics, Inc.
Location: Soleno Clinical Site Phoenix Arizona
Summary
Prospective observational study developed to generate more evidence of the safety profile, clinical characteristics and outcomes of patients with PWS treated with VYKAT XR.
Eligibility Criteria
Inclusion Criteria:
* Patients currently receiving or initiating treatment with VYKAT XR, including patients who previously received DCCR or are transitioning from DCCR to VYKAT XR in the context of a prior DCCR clinical trial.
* Patients and/or caregivers must provide written informed consent.
Source: ClinicalTrials.gov (NCT07450664). StuddyBuddy aggregates publicly available trial information.
